Kopenhamn, Denmark

Morten Soegaard


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Innovative Solutions by Morten Soegaard: A Study of His Patent Contributions**

Introduction

Morten Soegaard, a notable inventor based in Kopenhagen, Denmark, has made strides in the field of immunology through his innovative research and patents. His work primarily focuses on methods that enhance T-cell activation, providing potential advancements in medical therapies.

Latest Patents

Morten Soegaard holds a significant patent titled "Cytolysis of Target Cells by Superantigen Conjugates Inducing T-cell Activation." This patent presents a method for inactivating target cells in the presence of T cells by facilitating contact between the two cell types with a superantigen (SAG) and an immune modulator. Specifically, his invention emphasizes a unique conjugate format, wherein at least one component, either the superantigen or the immune modulator, is linked to a targeting moiety for efficient delivery to the target cells. The specification within the patent reveals a complex structure involving multiple moieties and organic linkers, highlighting innovative approaches in targeted immunotherapy.

Career Highlights

Morten is actively associated with Active Biotech AG, where he contributes to cutting-edge research and development efforts. His role in the company positions him at the forefront of biotechnology innovation, particularly in enhancing immune responses through precise methodologies.

Collaborations

In his journey towards advancing the field of immunology, Morten collaborates with distinguished colleagues such as Lars B Abrahmsen and Peter Lando. Their collective efforts in research aim to push the boundaries of conventional treatment methodologies, integrating innovative solutions into practical applications.

Conclusion

Morten Soegaard stands out as a key inventor with a significant patent that has the potential to improve therapeutic strategies in immunology. His contributions, alongside those of his collaborators, signify a forward-thinking approach to medical science, ultimately benefiting patient care and treatment efficacy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…